Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.
- 1 November 2019
- journal article
- review article
- Published by Elsevier in Psychiatry Research
- Vol. 281, 112556
Abstract
No abstract availableKeywords
Funding Information
- HEE (ICA-CL-2017-03-001)
- NIHR
- Maudsley NHS Foundation Trust
This publication has 48 references indexed in Scilit:
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controlsWorld Psychiatry, 2013
- Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and SwedenPLOS ONE, 2013
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar DisorderCNS Drugs, 2012
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trialsSchizophrenia Research, 2012
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-AnalysisSchizophrenia Bulletin, 2011
- Who is not adhering to physical activity referrals, and why?Scandinavian Journal of Primary Health Care, 2011
- Life expectancy among persons with schizophrenia or bipolar affective disorderSchizophrenia Research, 2011
- Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trialsThe British Journal of Psychiatry, 2008
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic DisordersCNS Drugs, 2008
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006